Documentos relacionados

1. [Pancreatic adenocarcinoma--a therapeutic challenge].
2. Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.
3. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
4. Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma.
5. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
6. Elevated preoperative plasma D-dimer level was an independent prognostic factor for patients with PDAC after curative resection: a retrospective analysis.
7. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
8. The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas.
9. Preoperative neutrophil-to-lymphocyte ratio behaves as an independent prognostic factor even in patients with postoperative complications after curative resection for gastric cancer.
10. A postsurgical prognostic nomogram for patients with lymph node positive rectosigmoid junction adenocarcinoma.